Neurocrine Biosciences, Inc. (NBIX)
127.68
-2.51
(-1.93%)
USD |
NASDAQ |
Apr 24, 16:00
127.69
+0.01
(+0.01%)
After-Hours: 20:00
Neurocrine Biosciences Market Cap : 12.81B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Soleno Therapeutics, Inc. | 2.722B |
| Glaukos Corp. | 7.110B |
| Edgewise Therapeutics, Inc. | 3.388B |
| Nuvalent, Inc. | 8.215B |
| Biogen, Inc. | 27.06B |
Market Cap Related Metrics
| PE Ratio | 27.35 |
| PS Ratio | 4.572 |
| PEG Ratio | 0.6539 |
| Price to Book Value | 3.939 |
| Price to Free Cash Flow | 17.47 |
| Price | 127.68 |
| Earnings Yield | 3.66% |
| PEGY Ratio | 0.6539 |
| Operating PE Ratio | 20.55 |
| Normalized PE Ratio | 26.53 |